|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001443,
umls-concept:C0008976,
umls-concept:C0023981,
umls-concept:C0034656,
umls-concept:C0035647,
umls-concept:C0035820,
umls-concept:C0040399,
umls-concept:C0155626,
umls-concept:C0162680,
umls-concept:C0206012,
umls-concept:C0206194,
umls-concept:C0220825,
umls-concept:C0302350,
umls-concept:C1096776,
umls-concept:C1274040,
umls-concept:C1337333
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-8-5
|
|
pubmed:abstractText |
Preliminary studies indicate that adenosine myocardial perfusion single photon tomography (SPECT) can safely and accurately stratify patients into low and high risk groups early after acute myocardial infarction (AMI).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1071-3581
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
458-69
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15295415-Adenosine,
pubmed-meshheading:15295415-Disease-Free Survival,
pubmed-meshheading:15295415-Female,
pubmed-meshheading:15295415-Humans,
pubmed-meshheading:15295415-Male,
pubmed-meshheading:15295415-Middle Aged,
pubmed-meshheading:15295415-Myocardial Infarction,
pubmed-meshheading:15295415-Prognosis,
pubmed-meshheading:15295415-Prospective Studies,
pubmed-meshheading:15295415-Radiopharmaceuticals,
pubmed-meshheading:15295415-Reproducibility of Results,
pubmed-meshheading:15295415-Risk Assessment,
pubmed-meshheading:15295415-Sensitivity and Specificity,
pubmed-meshheading:15295415-Survival Analysis,
pubmed-meshheading:15295415-Survivors,
pubmed-meshheading:15295415-Technetium Tc 99m Sestamibi,
pubmed-meshheading:15295415-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:15295415-Treatment Outcome,
pubmed-meshheading:15295415-United States
|
|
pubmed:articleTitle |
Adenosine sestamibi SPECT post-infarction evaluation (INSPIRE) trial: A randomized, prospective multicenter trial evaluating the role of adenosine Tc-99m sestamibi SPECT for assessing risk and therapeutic outcomes in survivors of acute myocardial infarction.
|
|
pubmed:affiliation |
The Methodist DeBakey Heart Center and Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030-2717, USA. johnj@bcm.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Validation Studies
|
